These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10075397)

  • 21. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia.
    Kantrowitz JT; Citrome L; Javitt DC
    Clin Ther; 2009 Jun; 31 Pt 1():1360-73. PubMed ID: 19698899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for the drug therapy of alcoholism].
    Gessa GL
    Recenti Prog Med; 1990 Mar; 81(3):171-5. PubMed ID: 2359869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-hydroxybutyric acid and alcohol-related syndromes.
    Moncini M; Masini E; Gambassi F; Mannaioni PF
    Alcohol; 2000 Apr; 20(3):285-91. PubMed ID: 10869871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB).
    Dimitrijevic N; Dzitoyeva S; Satta R; Imbesi M; Yildiz S; Manev H
    Eur J Pharmacol; 2005 Sep; 519(3):246-52. PubMed ID: 16129424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse.
    Castelli MP
    Mini Rev Med Chem; 2008 Oct; 8(12):1188-202. PubMed ID: 18855733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
    Caputo F; Francini S; Stoppo M; Lorenzini F; Vignoli T; Del Re A; Comaschi C; Leggio L; Addolorato G; Zoli G; Bernardi M
    J Psychopharmacol; 2009 Nov; 23(8):883-90. PubMed ID: 18635689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are the effects of gamma-hydroxybutyrate (GHB) treatment partly physiological in alcohol dependence?
    Ameisen O
    Am J Drug Alcohol Abuse; 2008; 34(2):235-6; author reply 237-8. PubMed ID: 18293241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.
    Kamal RM; Dijkstra BA; Loonen AJ; De Jong CA
    J Addict Med; 2016; 10(4):229-35. PubMed ID: 27310146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Update on gamma-hydroxybutyric acid].
    García FB; Pedraza C; Navarro JF
    Rev Neurol; 2006 Jul 1-15; 43(1):39-48. PubMed ID: 16807871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.
    Amsterdam JV; Brunt TM; Pereira FR; Crunelle CL; Brink WVD
    Curr Neuropharmacol; 2022; 20(4):809-819. PubMed ID: 34151766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists.
    Carter LP; Wu H; Chen W; Matthews MM; Mehta AK; Hernandez RJ; Thomson JA; Ticku MK; Coop A; Koek W; France CP
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1314-23. PubMed ID: 15769868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
    Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. γ-Hydroxybutyric acid-induced psychosis and seizures.
    Cagnin A; Pompanin S; Manfioli V; Briani C; Zambon A; Saladini M; Dam M
    Epilepsy Behav; 2011 Jun; 21(2):203-5. PubMed ID: 21530412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats.
    Fadda F; Colombo G; Mosca E; Gessa GL
    Alcohol Alcohol; 1989; 24(5):447-51. PubMed ID: 2818752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of an ethanol withdrawal syndrome in rats by butyrate, lactate and beta-hydroxybutyrate.
    Derr RF; Draves K; Derr M
    Life Sci; 1983 May; 32(22):2551-4. PubMed ID: 6682922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol for the treatment of alcohol withdrawal symptoms: a questionable approach.
    Müller CA; Hein J
    Neurologist; 2010 May; 16(3):211. PubMed ID: 20445435
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of ethanol and acetaldehyde on gamma-hydroxybutyric acid in rat brain and liver.
    Poldrugo F; Snead OC
    Subst Alcohol Actions Misuse; 1984; 5(5):263-71. PubMed ID: 6543478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.